Varian announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is what Varian calls the smallest multi-room system available for sale, with up to a 30 percent smaller footprint than the company's previous multi-room solution.
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a landmark study published in the journal Radiology.
During its annual meeting in September, the American Society for Radiation Oncology (ASTRO) issued a response to the Centers for Medicare and Medicaid Services’ (CMS) request for comment on a proposed advanced alternative payment model (APM) for radiation oncology. The statement, attributed to Paul Harari, M.D., chair of the ASTRO board of directors, listed several areas of concern where the association felt the proposed model falls short.
Consistency and accuracy of patient imaging saves millions of lives each year. None of which would be possible without ...
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates the immune system in some patients with metastatic non-small-cell lung cancer (NSCLC), increasing progression-free survival (PFS). Findings of the phase II randomized trial were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago.
September 18, 2019 — Although Medicare claims data confirm the increasing role of nurse practitioners and physician ...
The European Society of Cardiology (ESC) published new guidelines on the diagnosis and management of chronic coronary syndromes (CCS), which classifies computed tomography angiography (CTA) as a Class 1 recommendation for diagnosing CAD in symptomatic patients. The document, which is a continuation of the 2013 stable coronary artery disease (CAD) guidelines, updates the term to CCS to emphasize the dynamic nature of the disease. It was released at the 2019 ESC Congress, Aug. 31-Sept. 4 in Paris, France, and published simultaneously in the European Heart Journal.
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.
The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of angiography systems from Siemens Healthineers that permit a wide range of minimally invasive procedures to be performed in a single interventional suite. The Artis icono biplane system is engineered for optimal utilization in neuroradiology and abdominal imaging, while the Artis icono floor is a floor-mounted, single-plane system for vascular, interventional cardiology, surgical and oncology procedures. Both systems in the Artis icono family expand the reach of precision medicine.
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically ...
Early-stage detection is key to the prevention of life-threatening diseases; however, limited access to data hinders the ...
At the 2019 American Society for Radiation Oncology (ASTRO) Annual Meeting, running Sept. 15-18 in Chicago, Sun Nuclear Corp. will present novel advancements in radiation oncology quality management.
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, being held Sept. 15-18 in Chicago, Varian announced Ethos therapy, an artificial intelligence (AI)-driven holistic solution designed to increase the capability, flexibility and efficiency of radiotherapy. This new solution is designed to deliver an entire adaptive treatment in a typical 15-minute timeslot, from patient setup through treatment delivery.
Secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men. The researchers say this calls for rethinking treatment guidelines based on a patient’s post-operative prostate-specific antigen (PSA) level. Findings were presented at the 61st Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago.
Software automation can help improve many processes, including verifying eligibility for patient exams, navigating the ...
Siemens Healthineers debuted two computed tomography (CT) systems dedicated to radiation therapy (RT) planning at the 2019 annual meeting of the American Society for Radiation Oncology (ASTRO), Sept. 15-18 in Chicago. The new introductions include the Somatom go.Sim and the Somatom go.Open Pro, both of which are pending U.S. Food and Drug Administration (FDA) 510(k) clearance and are not yet commercially available in the United States.
Radiation dose management is central to child patient safety. Medical imaging plays an increasing role in the accurate diagnosis and treatment of numerous medical conditions. The speed, accuracy and noninvasiveness of medical imaging have also contributed to a sharp increase in the number of imaging procedures
Isoray Inc. announced it will spotlight the growing cancer treatment applications of Cesium-131 brachytherapy at the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago.
The Akesis Galaxy, a gamma stereotactic radiosurgery system (SRS) with continuous 360-degree rotational technology, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), making the system available to clinicians in the United States.
Philips will showcase its integrated radiation oncology portfolio at the American Society of Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago. Visitors to the Philips booth will experience Philips IntelliSpace Radiation Oncology, an intelligent patient management solution to manage complexity, improve efficiency and enable operational excellence in radiotherapy departments. The company will also highlight its Pinnacle Evolution treatment planning software, as well as its broad portfolio of connected oncology solutions designed to help health systems achieve the Quadruple Aim: an improved experience for patients and staff, better health outcomes and a lower cost of care.
People who live in rural America may deserve the same quality healthcare as anyone living in the U.S., but it is not ...
3D Systems has received additional U.S. Food and Drug Administration (FDA) 510(k) clearance for its D2P software allowing clinicians to 3-D print diagnostic patient-specific anatomic models.
Therapeutic oncology company RefleXion Medical announced it will showcase the RefleXion X1 Machine at the American Society for Radiation Oncology (ASTRO) 2019 annual meeting, Sept. 15-18 in Chicago. The company says its biology-guided radiotherapy (BgRT) platform is the first and only technology that unlocks the biological signature of each tumor to characterize its movement and direct highly conformal treatment to the tumor.